zanubrutinib,ibrutinib,venetoclax
abbvie,janssen,roche,beigene
['alpine', 'venetoclax', ' ibru', 'zanu ', 'lymsm']
time-limited ibrutinib + venetoclax for 2 years in frontline waldenstrom's. time to response 1.9 months. pfs was 92% and os 95% with ~1 year of follow-up. 2 grade 5 aes due to ventricular arrhythmias (known problem with ibrutinib). based on alpine, zanu instead? #ash22 #lymsm 
#lymsm & #mmsm hematologist & patient-reported outcomes researcher @CUHematology. Founder of https://t.co/kN6qeGXfg5, @inTrainingDoc & @inHouseMag. ??????